Compound Radar

Butterfly Network, Inc. (BFLY) Stock Analysis

United States · Healthcare / Medical Devices

Price $7.38
Market cap $1.97B
Next earnings Oct 29, 2026
Entry status Wait

Last updated Oct 27, 2026

Health Check

Last analyzed Oct 23, 2026

42
42/100 Avoid
  • Financial Health 25
  • Profitability 60
  • Business Quality 65
  • Balance Sheet 35
  • Cash Flow 25

Why this rating?

Health 42/100 — Avoid

Strongest Business Quality 65/100
Softest Cash Flow 25/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Butterfly Network, Inc. (BFLY) is a Medical Devices company in the Healthcare sector. Compound Radar rates Butterfly Network, Inc. 42/100 (Avoid) due to solid business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Stretched

Financial highlights

Valuation

  • Forward P/E -109.33
  • EV/Revenue 14.87

Profitability

  • Revenue Growth 39.5%
  • Gross Margin 68.2%
  • Operating Margin -30.9%
  • Net Margin -66.7%
  • ROE -35.5%

Financial strength

  • Cash $124.66M
  • Debt $19.10M
  • Net Cash $105.56M
  • Free Cash Flow $-16.05M
  • Current Ratio 4.06

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Butterfly Network, Inc. (BFLY).

View Methodology & FAQ →